Clearmind Medicine (CMND) Change in Cash (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Change in Cash of $2.2 million for Q2 2026, up 264.9% year-over-year from $591388.7 in Q2 2025, and down 59.55% quarter-over-quarter from $5.3 million in Q1 2026.
Clearmind Medicine (CMND) Change in Cash (2022 - 2026) Analysis & Trends
Clearmind Medicine's Change in Cash history runs 5 years deep, the most recent figure standing at $2.2 million for Q2 2026.
- In Q2 2026, Change in Cash rose 264.9% year-over-year to $2.2 million; the TTM figure through Apr 2026 stood at $6.9 million (up 281.12% YoY), while the FY2025 annual figure was -$2.7 million, down 331.29% from the prior year.
- Change in Cash for Q2 2026 stood at $2.2 million, down from $5.3 million in the prior quarter.
- The five-year high for Change in Cash was $2984.0 billion in Q4 2022, with the low at -$2984.0 billion in Q3 2022.
- The 5-year median for Change in Cash is -$626279.0 (2024), against an average of $544746.9.
- The sharpest annual moves came in 2024 and 2026: Change in Cash slumped 169.97% in 2024, then jumped 773.05% in 2026.
- Clearmind Medicine's Change in Cash stood at $2984.0 billion in 2022, then sank by 100.0% to $1.6 million in 2023, then plunged by 169.97% to -$1.1 million in 2024, then jumped by 138.68% to $427720.0 in 2025, then soared by 404.52% to $2.2 million in 2026.
- Business Quant data shows CMND's Change in Cash at $2.2 million in Q2 2026, $5.3 million in Q1 2026, and $427720.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.16 Mn |
| Jan 31, 2026 | 5.33 Mn |
| Oct 31, 2025 | 427,720.00 |
| Jul 31, 2025 | -977,182.00 |
| Apr 30, 2025 | -1.31 Mn |
| Jan 31, 2025 | -792,617.00 |
| Oct 31, 2024 | -1.11 Mn |
| Jul 31, 2024 | -626,279.00 |
| Apr 30, 2024 | -980,046.00 |
| Jan 31, 2024 | 3.86 Mn |
| Oct 31, 2023 | 1.58 Mn |
| Jul 31, 2023 | -1.40 Mn |
| Apr 30, 2023 | 1.88 Mn |
| Jan 31, 2023 | 3.24 Mn |
| Oct 31, 2022 | 2,983.98 Bn |
| Jul 31, 2022 | -2,983.98 Bn |
| Jan 31, 2022 | -1.41 Mn |